Paper - WANFANG MED ONLINE

You Position: Home > Paper

Intravenous immunoglobulin for the treatment of some dermatoses

( views:268, downloads:204 )

Author:: No author available

Journal Title:: International Journal of Dermatology and Venereology

Issue:: 2

DOI:: 10.3760/cma.j.issn.1673-4173.2015.02.008

Key Word:: 皮肤疾病;免疫球蛋白类;注射;治疗应用;Skin diseases;Immunoglobulins;Injections;Therapeutic uses

Abstract： Intravenous immunoglobulin (IVIG) was initially approved as an alternative to antibodies in the treatment of primary immunodeficiency diseases.With further insights into its action mechanism,IVIG has been successfully applied to the treatment of bullous dermatoses,connective tissue diseases,severe drug eruptions,Kawasaki disease,etc.It has been proved that IVIG has good therapeutic effect and increases the survival of patients.Although IVIG is relatively safe and well tolerable,it has some adverse effects.Currently,lack of large-scale randomized controlled trials (RCTs) remains the biggest problem.

Reference

[1]Annette Czernik,Siavash Toosi,Jean-Claude Bystryn,etc.Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: An update[J].2012,45(1).
[2]A. R. CROW,D. BRINC,A. H. LAZARUS.New insight into the mechanism of action of IVIg: the role of dendritic cells[J].2009,7.
[3]Doiron,Philip.Antepartum Intravenous Immunoglobulin Therapy in Refractory Pemphigoid Gestationis: Case Report and Literature Review.[J].2010,14(4).
[4]Camara,I.,Sciascia,S.,Simoes,J.,etc.Treatment with intravenous immunoglobulins in systemic lupus erythematosus: A series of 52 patients from a single centre[J].2014,32(1).
[5]Carolina Balbi,Mosqueira,Laura de Albuquerque,Furlani,Augusto Frederico de Paula,Xavier,etc.Intravenous immunoglobulin for treatment of severe acquired bullous epidermolysis refractory to conventional immunosuppressive therapy.[J].2011,85(4).
[6]Lolis M,Toosi S,Czernik A,etc.Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies.[J].2011,64(3).
[7]E. Fernández‐Cruz,D. Alecsandru,S. S. Ramón.Mechanisms of action of immune globulin[J].2009,157.
[8]Spurlock, N. K.,Prittie, J. E..A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin.[J].2011,21(5).
[9]Hyun Kwon, Kim,Jungeun, Oh,Young Mi, Hong,etc.Parameters to guide retreatment after initial intravenous immunoglobulin therapy in kawasaki disease.[J].2011,41.
[10]Chang PY,Ahmed AR,Foster CS.Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.[J].2010,117(5).
[11]Smith SD,Dennington PM,Cooper A.The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review.[J].2010,51(4).
[12]Nobuyuki Sugawara,Yayoi Nagai,Yoichiro Matsushima,etc.Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy[J].2007,57(6).
[13]Arti Nanda,Fatima Khawaja,Mousmee Nanda,etc.Linear immunoglobulin a bullous disease of childhood responsive to intravenous immunoglobulin monotherapy.[J].2012,29(4).
[14]Wang B,Xu H,Chen J,etc.High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson Syndrome and Toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.[J].2010,20(6).
[15]Gaitanis,G.,Alexis,I.,Pelidou,S.-H.,etc.High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid[J].2012,22(3).
[16]Timothy T. Kuo,Victoria G. Aveson.Neonatal Fc receptor and IgG-based therapeutics[J].2011,3(5).
[17]Prins, Christa,Gelfand, Erwin W.,French, Lars E..Intravenous Immunoglobulin: Properties, Mode of Action and Practical Use in Dermatology.[J].2007,87(3).
[18]Ahmed,A.R.,Gürcan,H.M..Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: Clinical outcome and post-treatment long-term follow-up[J].2012,26(9).
[19]Dong Xue Wang,Xiao Ming Shu,Xiao Lan Tian,etc.Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.[J].2012,31(5).
[20]Chen,S.,Chen,X.,Chen,G..Role of complement and perspectives for intervention in transplantation[J].2013,218(5).
[21]Lee,H.Y.,Lim,Y.L.,Thirumoorthy,T.,etc.The role of intravenous immunoglobulin in toxic epidermal necrolysis: A retrospective analysis of 64 patients managed in a specialized centre[J].2013,169(6).
[22]Vani J,Bayry J,Maddur MS,etc.Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin.[J].2011,127(3).